Chief, Division of Medical Psychiatry
Associate Chair for Hospital & Medical Psychiatry
Department of Psychiatry & Behavioral Sciences
Stanford University
Menlo Park, California
Dr. Maldonado is the John & Terry Levin Family Endowed Professor of Medicine, Associate Chair for Hospital & Medical Psychiatry, Chief - Division of Medical Psychiatry, and Chief - Critical Care Psychiatry Service - Stanford University School of Medicine.
Dr. Maldonado has received multiple awards and recognitions, the most recent include: the 2017 – Franz-Köhler-Inflammation-Award from the German Society of Anesthesiology and Intensive Care Medicine (DGAI) for extraordinary achievements in research on inflammation and its relationship to the pathophysiology of delirium; and the 2018 – Eleanor and Thomas P. Hackett Memorial Award by the Academy of Consultation-Liaison Psychiatry, the Academy’s highest honor, for distinctive achievements in CLP training, research, clinical practice, and leadership; and recipient of the 2024-Dlin/Fischer Clinical Research Award-for significant achievement in clinical research for the development of the Stanford Proxy Test for Delirium.
His research lab developed a number of tools for the prediction and assessment of various neuropsychiatric disorders, including the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) for assessing psychosocial candidacy of organ transplant candidates; the Stanford Proxy Test of Delirium (S-PTD)- for the development of a new tool for the timely and accurate diagnosis of delirium; the Stanford Algorithm for Predicting Delirium (SAPD), to help predict patients at risk for developing delirium; and the Prediction of Alcohol Withdrawal Severity Scale (PAWSS). He has developed management protocols and algorithms for the prevention and treatment of delirium; as well as novel pharmacological techniques (benzodiazepine-sparing protocol) for the prophylaxis and treatment of complicated alcohol withdrawal syndromes.
Wednesday, November 6, 2024
1:00 PM – 5:00 PM EST
Disclosure(s): No relevant disclosure to display
Thursday, November 7, 2024
3:05 PM – 4:20 PM EST
Disclosure(s): No relevant disclosure to display
An Energizing Symposium: Stimulants in the CL Setting and Beyond
Thursday, November 7, 2024
4:40 PM – 5:55 PM EST
Disclosure(s): No relevant disclosure to display
Friday, November 8, 2024
11:05 AM – 12:20 PM EST
Disclosure(s): No relevant disclosure to display
Friday, November 8, 2024
11:05 AM – 12:20 PM EST
Disclosure(s): No relevant disclosure to display
Dextroamphetamine as Adjunctive Pharmacotherapy for Aggression Secondary to Korsakoff Syndrome
Friday, November 8, 2024
1:35 PM – 2:50 PM EST
Disclosure(s): No relevant disclosure to display
Friday, November 8, 2024
1:35 PM – 2:50 PM EST
Disclosure(s): No relevant disclosure to display
Friday, November 8, 2024
1:35 PM – 2:50 PM EST
Disclosure(s): No relevant disclosure to display
Saturday, November 9, 2024
9:00 AM – 10:15 AM EST
Disclosure(s): No relevant disclosure to display
Virtual
Disclosure(s): No relevant disclosure to display